Genetic and epigenetic concept of SARS-CoV-2 targets in different renal cancer subtypes Farklı böbrek kanseri alt tiplerinde SARS-CoV-2 hedeflerinin genetik ve epigenetik konsepti


Akin-Bali D. F., Sagkan R. I.

Turkish Journal of Biochemistry, vol.46, no.2, pp.145-155, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1515/tjb-2020-0233/html
  • Journal Name: Turkish Journal of Biochemistry
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, Food Science & Technology Abstracts, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.145-155
  • Keywords: ACE2, CD147/BSG, COVID-19, FURIN, Methylation, Renal cancer, Severe acute respiratory syndrome coronavirus 2, TMPRSS2
  • Uşak University Affiliated: Yes

Abstract

Objectives: Recent advances in defining the genetic landscape of has shown the host cell- SARS-CoV-2 interaction via ACE2 protein and the presence of at least three additional virus invasion genes including TMPRSS2, FURIN, CD147/BSG. In current study, we investigated the mutation and m-RNA expression patterns of target genes by evaluating the associations between genetic and epigenetic mechanisms in the target genes and susceptibility of SARS-CoV-2 infection of renal cancer subtypes. Methods: We investigated the mutation and m-RNA expression patterns of our target genes. The promoter methylation profiles of target genes were tested in the UALCAN database. Results: The total rate of carrying genetic anomaly in the target genes including was 1.6% and seven mutations, one of which had a pathogenic feature, were detected. The expression analysis results in renal cancer groups showed that while the KIRC and KIRP patients had a lower level of TMPRSS2 than the healthy control, their ACE2 level was high. KICH patients had a higher level of CD147/BSG expression than the healthy group. The promoter methylation levels of ACE2 in KIRC and KIRP were reduced. Conclusions: We concluded that renal cancer patients may be more sensitive to SARS-CoV-2 infection, which may worsen the prognosis.